Phase II Clinical Study of PLM60 for the Treatment of Cutaneous T Cell Lymphomas

NCT02597153 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Just one subject enrolled in this trial during one and a half years.

Conditions

Relapsed Cutaneous T Cell Lymphom

Interventions

DRUG: Mitoxantrone HCL Liposome Injection

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.